Cargando…
Phytogalactolipid dLGG Inhibits Mouse Melanoma Brain Metastasis through Regulating Oxylipin Activity and Re-Programming Macrophage Polarity in the Tumor Microenvironment
SIMPLE SUMMARY: Metastatic brain melanoma is a common metastatic cancer with a high mortality rate. Current clinical regimens use the anti-angiogenesis drug bevacizumab (Avastin) and/or Lipo-DOX, a drug capable penetrating the blood–brain barrier; however, both commonly result in adverse side effect...
Autores principales: | Yang, Chung-Chih, Chang, Meng-Ting, Chang, Cheng-Kuei, Shyur, Lie-Fen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8391228/ https://www.ncbi.nlm.nih.gov/pubmed/34439274 http://dx.doi.org/10.3390/cancers13164120 |
Ejemplares similares
-
Phytogalactolipids activate humoral immunity against colorectal cancer
por: Lin, Han-Huei, et al.
Publicado: (2023) -
Identification of Serum Oxylipins Associated with the Development of Coronary Artery Disease: A Nested Case-Control Study
por: Chiang, Kuang-Mao, et al.
Publicado: (2022) -
Current Research and Development of Chemotherapeutic Agents for Melanoma
por: Hsan, Kyaw Minn, et al.
Publicado: (2010) -
Cumingianoside A, a Phyto-Triterpenoid Saponin Inhibits Acquired BRAF Inhibitor Resistant Melanoma Growth via Programmed Cell Death
por: Cvetanova, Biljana, et al.
Publicado: (2019) -
Current Advancements of Plant-Derived Agents for Triple-Negative Breast Cancer Therapy through Deregulating Cancer Cell Functions and Reprogramming Tumor Microenvironment
por: Wu, Tai-Na, et al.
Publicado: (2021)